Theranostics in Renal Cell Carcinoma-A Step Towards New Opportunities or a Dead End-A Systematic Review.
Jóźwik-Plebanek K, Saracyn M, Kołodziej M, Kamińska O, Durma AD, Mądra W, Gniadek-Olejniczak KA, Dedecjus M, Kucharz J, Stec R, Kamiński G.
Jóźwik-Plebanek K, et al. Among authors: durma ad.
Pharmaceuticals (Basel). 2024 Dec 19;17(12):1721. doi: 10.3390/ph17121721.
Pharmaceuticals (Basel). 2024.
PMID: 39770563
Review.